UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dysregulation of miRNA and its potential therapeutic application in schizophrenia

CNS neuroscience & therapeutics, 2018-07, Vol.24 (7), p.586-597

2018

Volltextzugriff (PDF)

Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach

Journal of neuroscience research, 2021-05, Vol.99 (5), p.1308-1324

2021

Volltextzugriff (PDF)

Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity

Acta pharmacologica Sinica, 2016-09, Vol.37 (10), p.1315-1324

2016

Volltextzugriff (PDF)

Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation‐induced cell death

Journal of neurochemistry, 2017-02, Vol.140 (4), p.589-604

2017

Volltextzugriff (PDF)

The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway

Acta pharmacologica Sinica, 2019-10, Vol.40 (10), p.1292-1302

2019

Volltextzugriff (PDF)

Emerging novel approaches to drug research and diagnosis of Parkinson’s disease

Acta pharmacologica Sinica, 2020-04, Vol.41 (4), p.439-441

2020

Volltextzugriff (PDF)

Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin

Acta pharmacologica Sinica, 2020-04, Vol.41 (4), p.499-507

2020

Volltextzugriff (PDF)

Emerging and evolving concepts in the pathobiology and treatment of psychosis

CNS neuroscience & therapeutics, 2018-07, Vol.24 (7), p.583-585

2018

Volltextzugriff (PDF)

Glial Pathology in Bipolar Disorder: Potential Therapeutic Implications

CNS neuroscience & therapeutics, 2015-05, Vol.21 (5), p.393-397

2015

Volltextzugriff (PDF)

Allosteric Modulation of Sigma‐1 Receptors Elicits Rapid Antidepressant Activity

CNS neuroscience & therapeutics, 2016-05, Vol.22 (5), p.368-377

2016

Volltextzugriff (PDF)

Small Molecules Selectively Targeting Sigma‑1 Receptor for the Treatment of Neurological Diseases

Journal of medicinal chemistry, 2020-12, Vol.63 (24), p.15187-15217

2020

Volltextzugriff (PDF)

Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action

PloS one, 2012-12, Vol.7 (12), p.e51910-e51910

2012

Volltextzugriff (PDF)

Mutation of SLC35D3 causes metabolic syndrome by impairing dopamine signaling in striatal D1 neurons

PLoS genetics, 2014-02, Vol.10 (2), p.e1004124

2014

Volltextzugriff (PDF)

GSK‐3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia

CNS neuroscience & therapeutics, 2017-02, Vol.23 (2), p.174-187

2017

Volltextzugriff (PDF)

Protease Omi facilitates neurite outgrowth in mouse neuroblastoma N2a cells by cleaving transcription factor E2F1

Acta pharmacologica Sinica, 2015-08, Vol.36 (8), p.966-975

2015

Volltextzugriff (PDF)

Dynamic regulation of excitatory and inhibitory synaptic transmission by growth hormone in the developing mouse brain

Acta pharmacologica Sinica, 2023-06, Vol.44 (6), p.1109-1121

2023

Volltextzugriff (PDF)

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

Acta pharmacologica Sinica, 2013-09, Vol.34 (9), p.1149-1155

2013

Volltextzugriff (PDF)

The classical D1 dopamine receptor antagonist SCH23390 is a functional sigma-1 receptor allosteric modulator

Acta pharmacologica Sinica, 2024-08, Vol.45 (8), p.1582-1590

2024

Volltextzugriff (PDF)

Absence of TRIM32 Leads to Reduced GABAergic Interneuron Generation and Autism-like Behaviors in Mice via Suppressing mTOR Signaling

Cerebral cortex (New York, N.Y. 1991), 2020-05, Vol.30 (5), p.3240-3258

2020

Volltextzugriff (PDF)

l-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT1A receptor partial agonistic activity

Synapse (New York, N.Y.), 2011-05, Vol.65 (5), p.379-387

2011

Volltextzugriff (PDF)

Effects of SKF83959 on the excitability of hippocampal CA1 pyramidal neurons： a modeling study

Acta pharmacologica Sinica, 2014-06, Vol.35 (6), p.738-751

2014

Volltextzugriff (PDF)

Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays

Acta pharmacologica Sinica, 2022-06, Vol.43 (6), p.1508-1520

2022

Volltextzugriff (PDF)

Limonoids from the Twigs and Leaves of Chukrasia tabularis

Helvetica chimica acta, 2008-12, Vol.91 (12), p.2338-2350

2008

Volltextzugriff (PDF)

Structural optimizations and bioevaluation of N-H aporphine analogues as Gq-biased and selective serotonin 5-HT2C receptor agonists

Bioorganic chemistry, 2022-06, Vol.123, p.105795-105795, Article 105795

2022

Volltextzugriff (PDF)

Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia

Schizophrenia research, 2008-12, Vol.106 (2), p.218-228

2008

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(85)
Buchkapitel
(2)

Sprache

Englisch
(85)
Chinesisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dysregulation of miRNA and its potential therapeutic application in schizophrenia

Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach

Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity

Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation‐induced cell death

The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway

Emerging novel approaches to drug research and diagnosis of Parkinson’s disease

Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin

Emerging and evolving concepts in the pathobiology and treatment of psychosis

Glial Pathology in Bipolar Disorder: Potential Therapeutic Implications

Allosteric Modulation of Sigma‐1 Receptors Elicits Rapid Antidepressant Activity

Small Molecules Selectively Targeting Sigma‑1 Receptor for the Treatment of Neurological Diseases

Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action

Mutation of SLC35D3 causes metabolic syndrome by impairing dopamine signaling in striatal D1 neurons

GSK‐3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia

Protease Omi facilitates neurite outgrowth in mouse neuroblastoma N2a cells by cleaving transcription factor E2F1

Dynamic regulation of excitatory and inhibitory synaptic transmission by growth hormone in the developing mouse brain

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

The classical D1 dopamine receptor antagonist SCH23390 is a functional sigma-1 receptor allosteric modulator

Absence of TRIM32 Leads to Reduced GABAergic Interneuron Generation and Autism-like Behaviors in Mice via Suppressing mTOR Signaling

l-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT1A receptor partial agonistic activity

Effects of SKF83959 on the excitability of hippocampal CA1 pyramidal neurons： a modeling study

Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays

Limonoids from the Twigs and Leaves of Chukrasia tabularis

Structural optimizations and bioevaluation of N-H aporphine analogues as Gq-biased and selective serotonin 5-HT2C receptor agonists

Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia

Suchergebnisse filtern